The European Commission approved on Friday the proposed merger of US drug manufacturers Pfizer and Wyeth, subject to Pfizer renouncing some of its animal health products in Europe.
Pfizer, already the world’s biggest pharmaceutical firm, announced the planned merger in January, seeking diversification as it prepares for the expiration of patents on its blockbuster drugs.
The US$68 billion deal appears to be the biggest takeover in the global pharmaceutical sector since Pfizer acquired Warner-Lambert Co for US$93.4 billion in 2000, financial analysts say.
COMMITMENT
The EU’s executive branch, which enforces EU competition law, said the merger was conditional on “Pfizer’s commitment to divest several types of animal health vaccines, pharmaceuticals and medicinal feed additives” in Europe.
“The commission had concerns that the transaction, as originally notified, would have raised competition issues in the field of animal health products on a number of national markets,” it said in a statement.
“In the light of the commitments offered by Pfizer, the Commission has now concluded that the proposed transaction would not significantly impede effective competition in the EEA or any substantial part of it.”
The European Economic Area (EEA) includes the 27 EU member states plus Iceland, Liechtenstein and Norway.
DIVESTMENT
In addition, the European Commission said Pfizer — best known for the anti-cholesterol treatment Lipitor and erectile dysfunction drug Viagra, as well as AIDS drugs — has offered to “divest” a Wyeth plant in Sligo, Ireland.
“In the area of human health, the companies’ activities are to a large extent complementary,” it said.
The merger still awaits a green light from competition authorities in the US, China and other jurisdictions, as well as approval from Wyeth shareholders, a statement on Pfizer’s Web site said.
If the deal goes ahead, the combined company will be No. 1 in terms of biopharmaceutical revenues in the US with a market share of about 12 percent. It will hold about 10 percent of the market in Europe.
When Lika Megreladze was a child, life in her native western Georgian region of Guria revolved around tea. Her mother worked for decades as a scientist at the Soviet Union’s Institute of Tea and Subtropical Crops in the village of Anaseuli, Georgia, perfecting cultivation methods for a Georgian tea industry that supplied the bulk of the vast communist state’s brews. “When I was a child, this was only my mum’s workplace. Only later I realized that it was something big,” she said. Now, the institute lies abandoned. Yellowed papers are strewn around its decaying corridors, and a statue of Soviet founder Vladimir Lenin
UNCERTAINTIES: Exports surged 34.1% and private investment grew 7.03% to outpace expectations in the first half, although US tariffs could stall momentum The Chung-Hua Institution for Economic Research (CIER, 中華經濟研究院) yesterday raised its GDP growth forecast to 3.05 percent this year on a robust first-half performance, but warned that US tariff threats and external uncertainty could stall momentum in the second half of the year. “The first half proved exceptionally strong, allowing room for optimism,” CIER president Lien Hsien-ming (連賢明) said. “But the growth momentum may slow moving forward due to US tariffs.” The tariff threat poses definite downside risks, although the scale of the impact remains unclear given the unpredictability of US President Donald Trump’s policies, Lien said. Despite the headwinds, Taiwan is likely
UNIFYING OPPOSITION: Numerous companies have registered complaints over the potential levies, bringing together rival automakers in voicing their reservations US President Donald Trump is readying plans for industry-specific tariffs to kick in alongside his country-by-country duties in two weeks, ramping up his push to reshape the US’ standing in the global trading system by penalizing purchases from abroad. Administration officials could release details of Trump’s planned 50 percent duty on copper in the days before they are set to take effect on Friday next week, a person familiar with the matter said. That is the same date Trump’s “reciprocal” levies on products from more than 100 nations are slated to begin. Trump on Tuesday said that he is likely to impose tariffs
HELPING HAND: Approving the sale of H20s could give China the edge it needs to capture market share and become the global standard, a US representative said The US President Donald Trump administration’s decision allowing Nvidia Corp to resume shipments of its H20 artificial intelligence (AI) chips to China risks bolstering Beijing’s military capabilities and expanding its capacity to compete with the US, the head of the US House Select Committee on Strategic Competition Between the United States and the Chinese Communist Party said. “The H20, which is a cost-effective and powerful AI inference chip, far surpasses China’s indigenous capability and would therefore provide a substantial increase to China’s AI development,” committee chairman John Moolenaar, a Michigan Republican, said on Friday in a letter to US Secretary of
RSS